CRO for Clinical Trials in Metabolic Disorders

Metabolic diseases disrupt normal metabolism, which is the process of converting food to energy on a cellular level. A metabolic disorder occurs when the metabolism process does not work well and causes the body to have either too much or too little of the essential substances.

Sofpromed is a clinical research organization (CRO) specialized in the management of phase I-IV clinical trials in metabolic diseases. We manage trials in the United States, Europe, United Kingdom, and globally.

Among others, we are able to manage clinical trials in diabetes, familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, MELAS, Niemann-Pick, phenylketonuria (PKU), porphyria, Tay-Sachs disease, and Wilson’s disease.

Our CRO services include:

  • Regulatory affairs
  • Clinical operations
  • Site selection and activation
  • Site management
  • Monitoring
  • Data management
  • Biostatistics
  • Statistical programming
  • Medical writing
  • Clinical supply and drug logistics

Please do not hesitate to contact us to obtain additional information about our CRO services for clinical trials in metabolic disorders.